Detalhe da pesquisa
1.
Insight into the mechanism of CD34+ cell mobilisation impairment in multiple myeloma patients treated with anti-CD38 therapy.
Br J Haematol
; 204(4): 1439-1449, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-37807708
2.
Involvement of Small Non-Coding RNA and Cell Antigens in Pathogenesis of Extramedullary Multiple Myeloma.
Int J Mol Sci
; 23(23)2022 Nov 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-36499093
3.
Monoclonal antibodies in the treatment of AL amyloidosis: co-targetting the plasma cell clone and amyloid deposits.
Br J Haematol
; 189(2): 228-238, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32072615
4.
Osteolytic bone lesions, hypercalcemia and paraprotein, but not a myeloma: case report and review of literature.
Vnitr Lek
; 66(5): 90-95, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32942878
5.
Venetoclax plus bortezomib and dexamethasone in heavily pretreated end-stage myeloma patients without t(11;14): A real-world cohort.
Hematol Oncol
; 38(3): 412-414, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32323881
6.
Single-agent venetoclax induces MRD-negative response in relapsed primary plasma cell leukemia with t(11;14).
Am J Hematol
; 94(1): E35-E37, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30370955
7.
The Benefit of Telemonitoring in the Prevention of Septic Shock in a Patient with Aggressive Non-Hodgkin's Lymphoma.
Case Rep Oncol
; 16(1): 143-150, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36908809
8.
An economic evaluation of the effectiveness of telemedicine in hematooncology.
PLoS One
; 18(11): e0291143, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37963144
9.
Clinical characteristics and outcomes in risk-stratified patients with smoldering multiple myeloma: data from the Czech Republic Registry of Monoclonal Gammopathies.
Blood Cancer J
; 13(1): 153, 2023 09 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37752128
10.
More Than 2% of Circulating Tumor Plasma Cells Defines Plasma Cell Leukemia-Like Multiple Myeloma.
J Clin Oncol
; 41(7): 1383-1392, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36315921
11.
Management of Treatment-Related Infectious Complications in High-Risk Hemato-Oncological Patients via Telemedicine.
Cancer Manag Res
; 14: 1655-1661, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35547597
12.
The deubiquitinase OTUD1 regulates immunoglobulin production and proteasome inhibitor sensitivity in multiple myeloma.
Nat Commun
; 13(1): 6820, 2022 11 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36357400
13.
Cytarabine + G-CSF is more effective than cyclophosphamide + G-CSF as a stem cell mobilization regimen in multiple myeloma.
Bone Marrow Transplant
; 54(7): 1107-1114, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30459429
14.
Limited efficacy of daratumumab in multiple myeloma with extramedullary disease.
Leukemia
; 36(1): 288-291, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34247197
15.
Mutation landscape of multiple myeloma measurable residual disease: identification of targets for precision medicine.
Blood Adv
; 6(2): 368-372, 2022 01 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34500459
16.
Urine immunofixation negativity is not necessary for complete response in intact immunoglobulin multiple myeloma: Retrospective real-world confirmation.
Int J Lab Hematol
; 43(5): e244-e247, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33452712